3D Systems Corp (NYSE: DDD) is an additive manufacturing company that designs, produces, and sells 3D printing hardware, materials, software, and related services across Healthcare and Industrial end markets. Revenue comes from two streams: product sales, primarily 3D printers and proprietary printing materials, and services, including application development, maintenance, and advanced manufacturing. Products generated $223.4 million and services $163.5 million in FY2025 total revenue of $386.9 million, down 12.1% from $440.1 million in FY2024, driven by lower materials volume in dental, service bureau, and jewelry markets and the impact of divestitures. The company operates two reporting segments: Healthcare Solutions and Industrial Solutions. Headquartered in Rock Hill, South Carolina, 3D Systems maintains manufacturing facilities in the U.S., France, Switzerland, and the Netherlands, with leased facilities across the Americas, EMEA, and APAC regions. The company does not pay a dividend and lists on the NYSE under the ticker DDD.
3D printing hardware for polymer and metal applications; proprietary materials sold in smart cartridges designed for integrated printer systems; 3D Sprint software for polymer print preparation and workflow management using AI and machine learning; advanced manufacturing services; application development and technical services. The company also conducts early-stage research into 3D-printed human organs, with a focus on lung tissue engineering initiated via a strategic partnership in 2017.
Transactional product sales of 3D printers and proprietary materials packaged in smart cartridges, supplemented by service revenue from application development, maintenance, upgrades, and advanced manufacturing. The business model targets recurring materials consumption as customers adopt additive manufacturing workflows. Product revenue was $223.4 million and service revenue was $163.5 million for the year ended December 31, 2025 (FY2025 10-K, filed 2026-03-09).
End markets include healthcare (dental, medical devices, organ bioprinting research), industrial (automotive, consumer, jewelry), and service bureaus. Product revenue decline in FY2025 was attributed specifically to lower materials volume in the dental, service bureau, and jewelry markets, as well as the impact of divestitures.
Global operations with leased facilities across the Americas, EMEA, and APAC. Manufacturing facilities in Rock Hill, South Carolina and Colorado Springs, Colorado (U.S.), Riom, France, Marly, Switzerland, and Soesterberg, Netherlands. Headquarters in Rock Hill, South Carolina (as of December 31, 2025).
Loading...